Reply to Phillips, Morris, and Walker.
Publication
, Journal Article
Evans, S; Follmann, D; Schoenfeld, D; Fowler, VG; Chambers, HF
Published in: Clin Infect Dis
March 15, 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
March 15, 2016
Volume
62
Issue
6
Start / End Page
815 / 816
Location
United States
Related Subject Headings
- Research Design
- Microbiology
- Humans
- Drug Resistance, Bacterial
- Clinical Trials as Topic
- Anti-Bacterial Agents
- 3202 Clinical sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Evans, S., Follmann, D., Schoenfeld, D., Fowler, V. G., & Chambers, H. F. (2016). Reply to Phillips, Morris, and Walker. Clin Infect Dis, 62(6), 815–816. https://doi.org/10.1093/cid/civ1003
Evans, Scott, Dean Follmann, David Schoenfeld, Vance G. Fowler, and Henry F. Chambers. “Reply to Phillips, Morris, and Walker.” Clin Infect Dis 62, no. 6 (March 15, 2016): 815–16. https://doi.org/10.1093/cid/civ1003.
Evans S, Follmann D, Schoenfeld D, Fowler VG, Chambers HF. Reply to Phillips, Morris, and Walker. Clin Infect Dis. 2016 Mar 15;62(6):815–6.
Evans, Scott, et al. “Reply to Phillips, Morris, and Walker.” Clin Infect Dis, vol. 62, no. 6, Mar. 2016, pp. 815–16. Pubmed, doi:10.1093/cid/civ1003.
Evans S, Follmann D, Schoenfeld D, Fowler VG, Chambers HF. Reply to Phillips, Morris, and Walker. Clin Infect Dis. 2016 Mar 15;62(6):815–816.
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
March 15, 2016
Volume
62
Issue
6
Start / End Page
815 / 816
Location
United States
Related Subject Headings
- Research Design
- Microbiology
- Humans
- Drug Resistance, Bacterial
- Clinical Trials as Topic
- Anti-Bacterial Agents
- 3202 Clinical sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences